Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Addex Therapeutics(ADXN) the Revenue is 9.616 K (-88.07%);the EBIT is -599.91 K (+12.76%);the EPS is -2.17 (-6.28%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B88.07%
----
----
EBIT
-0.00B12.76%
----
----
EPS
-2.16666.28%
----
----
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 24, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf